Metformin Cancer Risk Acceptable at 1 in 550,000 Patients: NIHS Assessment

October 1, 2020
The Ministry of Health, Labor and Welfare (MHLW) reported on September 30 the results of a health impact assessment of products containing the diabetes drug metformin in which the carcinogen N-nitrosodimethylamine (NDMA) has been detected, saying that using 1,500 mg...read more